title: [Esophageal candidiasis during interferon therapy for chronic viral hepatitis C].
authors.forename: J M
authors.initials: JM
authors.lastname: Prignet
authors.forename: M
authors.initials: M
authors.lastname: Galzin
authors.forename: J F
authors.initials: JF
authors.lastname: Demarquay
authors.forename: B
authors.initials: B
authors.lastname: Raynard
authors.forename: S
authors.initials: S
authors.lastname: Louvety
authors.forename: D
authors.initials: D
authors.lastname: Künkel
mesh_terms: D002177:Candidiasis / Q000139:chemically induced* / Q000188:drug therapy / Q000382:microbiology; D004935:Esophageal Diseases / Q000139:chemically induced* / Q000188:drug therapy / Q000382:microbiology; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use; D006526:Hepatitis C / Q000628:therapy*; D006521:Hepatitis, Chronic / Q000628:therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D011994:Recombinant Proteins
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D015725:Fluconazole
vernacular_title: Candidose oesophagienne au cours d'un traitement par l'interféron d'une hépatite chronique à virus C.